查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1279649

2022-2029年全球生物工程蛋白藥物市場規模研究與預測，按藥物類型、疾病、技術、給藥方式和區域分析。

Global Bioengineered protein drugs Market Size study & Forecast, by Drug Type by Disease, by Technology, by Drug Delivery Method and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

生物工程蛋白作為有效的治療性蛋白質，被創造為所有生物過程的重要參與者。這些獨特的藥物因其特異性、安全性、生物反應性和治療嚴重疾病和傷害的成功率而引起了製藥行業的興趣。由生物工程蛋白製成的藥物是生物過程和有效療法開發的關鍵參與者。由生物工程蛋白製成的藥物含有多種物品，包括激素、疫苗、細胞因數和單克隆抗體。由於癌症，糖尿病和其他疾病等各種疾病的患病率上升以及個人化醫療的發展等因素，生物工程蛋白藥物市場正在擴大。

根據國際癌症研究機構（IARC）的估計，2018年有1700萬新的癌症病例和950萬與癌症有關的死亡病例，估計到2040年將增加到2750萬新病例，全球癌症流行率的上升正在促進市場增長。增長速度最快的慢性病之一是糖尿病。近幾十年來，其發病率穩步上升。世界衛生組織預測，到2021年，糖尿病將影響全球5.37億人，每10人中就有1人患上其他形式的疾病。此外，老年和肥胖的人群更有可能患上慢性疾病。世界銀行集團估計，2020年全球有7.27億老年公民，在未來30年裡，這個數位將增加兩倍，到2050年達到15億。此外，該地區不斷增加的藥物發現活動和不斷增加的醫療保健研究和開發活動正在促進市場增長。然而，在2022-2029年的預測期內，生物工程蛋白藥物的高成本抑制了市場增長。

全球生物工程蛋白藥物市場研究的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於品牌產品的主導地位和該地區日益增長的疾病流行率，北美在收入方面主導了市場。而亞太地區在預測期內預計將以最高的複合年增長率增長，原因是老年病和目標人群的增加，產品開發合作的數量增加，主要參與者的地理擴張，以及政府和非營利組織對市場空間的積極參與等因素。

該研究的目的是定義近年來不同市場區隔和國家的市場規模，並預測未來幾年的價值。該報告旨在涵蓋參與研究的國家/地區的該行業的定性和定量方面。

該報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來增長。此外，它還涵蓋了微觀市場的潛在機會，供利益相關者投資，並詳細分析了主要參與者的競爭格局和藥物類型的報價。 .

目錄

第一章：執行摘要

  • 市場簡介
  • 2019-2029年全球及細分市場的估計和預測
    • 2019-2029年生物工程蛋白藥物市場，按地區分類
    • 2019-2029年生物工程蛋白藥物市場，按藥物類型分類
    • 2019-2029年，按疾病分類的生物工程蛋白藥物市場
    • 2019-2029年，按技術分類，生物工程蛋白藥物市場
    • 2019-2029年，按給藥方式分類，生物工程蛋白藥物市場
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章：全球生物工程蛋白藥物市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 研究的範圍
    • 行業演變
  • 研究涵蓋的年份
  • 貨幣兌換率

第三章：全球生物工程蛋白藥物市場動態

  • 生物工程蛋白藥物市場影響分析（2019-2029年）
    • 市場驅動力
      • 癌症和糖尿病等各種疾病的發病率不斷上升
      • 個性化醫療的不斷發展
    • 市場挑戰
      • 生物工程蛋白藥物的高成本
    • 市場機會
      • 配方的進步

第四章：全球生物工程蛋白藥物市場行業分析

  • 波特五力模型
    • 供應商的議價能力
    • 買方的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力模型的未來方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 經濟
    • 社會
    • 技術
  • 最佳投資機會
  • 最佳策略
  • 行業專家展望
  • 分析師建議和結論

第五章：風險評估：COVID-19的影響

  • 評估COVID-19對行業的整體影響
  • COVID-19前和COVID-19後的市場情況

第六章：全球生物工程蛋白藥物市場，按藥物類型分類

  • 市場簡介
  • 全球生物工程蛋白藥物市場，按藥物類型，性能-潛力分析
  • 2019-2029年全球生物工程蛋白藥物市場按藥物類型估計和預測的情況
  • 生物工程蛋白藥物市場，次級細項分析
    • 重組蛋白藥物
    • 肽類荷爾蒙
    • 疫苗
    • 治療性酶
    • 單克隆抗體
    • 細胞因子
    • 其他

第7章：全球生物工程蛋白藥物市場，按疾病分類

  • 市場簡介
  • 按疾病分類的全球生物工程蛋白藥物市場，性能-潛力分析
  • 2019-2029年全球生物工程蛋白藥物市場按疾病的估計和預測
  • 生物工程蛋白藥物市場，次級細項分析
    • 糖尿病
    • 癌症
    • 皮膚病
    • 血液疾病
    • 心髒病
    • 神經退行性疾病
    • 其他疾病

第八章：全球生物工程蛋白藥物市場，按技術分類

  • 市場簡介
  • 按技術分類的全球生物工程蛋白藥物市場，性能-潛力分析
  • 2019-2029年全球生物工程蛋白藥物市場按技術的估計和預測
  • 生物工程蛋白藥物市場，次級細項分析
    • 分餾法
    • 生物反應器和微生物細胞發酵
    • 基因工程
    • 轉基因生物
    • 製藥
    • 其他

第九章：全球生物工程蛋白藥物市場，按給藥方式分類

  • 市場簡介
  • 按給藥方式分類的全球生物工程蛋白藥物市場，表現- 潛力分析
  • 2019-2029年全球生物工程蛋白藥物市場按給藥方式的估計和預測
  • 生物工程蛋白藥物市場，次級細項分析
    • 傳統方法
    • 根據最近的研究，新的方法

第十章：全球生物工程蛋白藥物市場，區域分析

  • 生物工程蛋白藥物市場，區域市場簡介
  • 北美洲
    • 美國。
      • 藥物類型細分估計和預測，2019-2029年
      • 疾病分類估計和預測，2019-2029年
      • 技術分類估計和預測，2019-2029年
      • 2019-2029年，給藥方式分類估計和預測
    • 加拿大
  • 歐洲生物工程蛋白藥物市場簡介
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區生物工程蛋白藥物市場簡介
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉丁美洲生物工程蛋白藥物市場簡介
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 世界其他地區

第十一章：競爭情報

  • 頂級市場戰略
  • 公司簡介
    • Abbott Laboratories
      • 關鍵資訊
      • 縱覽
      • 財務（取決於數據的可用性）
      • 產品摘要
      • 最近的發展情況
    • Amgen
    • Baxter Healthcare
    • Bayer Healthcare Pharmaceuticals
    • Eli Lilly And Co.
    • GlaxoSmithKline
    • Hoffman-la-Roche
    • Johnson And Johnson
    • Merck And Co. Inc.,
    • Fresenius Kabi USA

第十二章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Bioengineered protein drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Bioengineered proteins, which serve as potent therapeutic proteins, are created to be essential participants in all biological processes. These unique medications are attracting interest from the pharmaceutical industry due to their specificity, safety, bio reactivity, and success rate in treating serious illnesses and injuries. Drugs made from bioengineered proteins are key players in the biological process and the development of effective therapeutics. The medication made from bioengineered proteins contains a variety of items, including hormones, vaccines, cytokines, and monoclonal antibodies. The Bioengineered protein drugs market is expanding because of factors such as rising prevelance of various diseases such as cancer, diabetes and other diseases as well as rising development of personalized medicine.

Rising prevelance of cancer globally is fostering the market growth, , according to estimates from the International Agency for Research on Cancer (IARC), there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018 and it is estimated increase to 27.5 million new cases by 2040. One of the chronic diseases with the quickest rate of growth is diabetes. In recent decades, its prevalence has steadily increased. The World Health Organization projects that by 2021, diabetes will affect 537 million individuals worldwide, with one in ten developing other forms of the disease. Moreover, populations that are elderly and fat are more likely to develop chronic diseases. The World Bank Group estimates that there were 727 million senior citizens worldwide in 2020, and that number will triple over the next three decades, reaching 1.5 billion by 2050. In addition, rising drug discovery activities, and rising healthcare research and development activities in the region is fostering the market growth. However, the high cost of Bioengineered protein drugs stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bioengineered protein drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Abbott Laboratories
  • Amgen
  • Baxter Healthcare
  • Bayer Healthcare Pharmaceuticals
  • Eli Lilly And Co.
  • GlaxoSmithKline
  • Hoffman-la-Roche
  • Johnson And Johnson
  • Merck And Co. Inc.,
  • Fresenius Kabi USA

Recent Developments in the Market:

  • In April 2022, Satellite Bio introduces a fresh method for creating tissues using bioengineering. This company has expertise in synthetic biology, regenerative medicine, cell therapy, cell biology, and tissue engineering.
  • In January 2022, A new biotechnology company named Altos Laboratories was founded with the goal of deciphering the intricate biology underlying the cellular renewal programming.

Global Bioengineered protein drugs Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Type, Diseases, Technology, Drug Delivery Methods, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Drug Typeofferings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Type:

  • Recombinant Protein Drugs
  • Peptide Hormones
  • Vaccines
  • Therapeutic Enzymes
  • Monoclonal Antibodies
  • Cytokines
  • Others

By Disease:

  • Diabetes
  • Cancer
  • Skin Diseases
  • Blood disorders
  • Heart Diseases
  • Neurodegenerative Diseases
  • Others

By Technology:

  • Fractionation
  • Bioreactors And Microbial Cell Fermentation
  • Genetic Engineering
  • Genetically Modified Organisms
  • Pharming
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Bioengineered protein drugs Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Bioengineered protein drugs Market, by Drug Type, 2019-2029 (USD Billion)
    • 1.2.3. Bioengineered protein drugs Market, by Diseases, 2019-2029 (USD Billion)
    • 1.2.4. Bioengineered protein drugs Market, by Technology, 2019-2029 (USD Billion)
    • 1.2.5. Bioengineered protein drugs Market, by Drug Delivery Method, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Bioengineered protein drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Bioengineered protein drugs Market Dynamics

  • 3.1. Bioengineered protein drugs Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevelance of various diseases such as cancer and diabetes
      • 3.1.1.2. Growing development of personalised medicine
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Bioengineered protein drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in Formulation

Chapter 4. Global Bioengineered protein drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Bioengineered protein drugs Market, by Drug Type

  • 6.1. Market Snapshot
  • 6.2. Global Bioengineered protein drugs Market by Drug Type, Performance - Potential Analysis
  • 6.3. Global Bioengineered protein drugs Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
  • 6.4. Bioengineered protein drugs Market, Sub Segment Analysis
    • 6.4.1. Recombinant Protein Drugs
    • 6.4.2. Peptide Hormones
    • 6.4.3. Vaccines
    • 6.4.4. Therapeutic Enzymes
    • 6.4.5. Monoclonal Antibodies
    • 6.4.6. Cytokines
    • 6.4.7. Others

Chapter 7. Global Bioengineered protein drugs Market, by Diseases

  • 7.1. Market Snapshot
  • 7.2. Global Bioengineered protein drugs Market by Diseases, Performance - Potential Analysis
  • 7.3. Global Bioengineered protein drugs Market Estimates & Forecasts by Diseases 2019-2029 (USD Billion)
  • 7.4. Bioengineered protein drugs Market, Sub Segment Analysis
    • 7.4.1. Diabetes
    • 7.4.2. Cancer
    • 7.4.3. Skin Diseases
    • 7.4.4. Blood disorders
    • 7.4.5. Heart Diseases
    • 7.4.6. Neurodegenerative Diseases
    • 7.4.7. Others

Chapter 8. Global Bioengineered protein drugs Market, by Technology

  • 8.1. Market Snapshot
  • 8.2. Global Bioengineered protein drugs Market by Technology, Performance - Potential Analysis
  • 8.3. Global Bioengineered protein drugs Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
  • 8.4. Bioengineered protein drugs Market, Sub Segment Analysis
    • 8.4.1. Fractionation
    • 8.4.2. Bioreactors And Microbial Cell Fermentation
    • 8.4.3. Genetic Engineering
    • 8.4.4. Genetically Modified Organisms
    • 8.4.5. Pharming
    • 8.4.6. Others

Chapter 9. Global Bioengineered protein drugs Market, by Drug Delivery Method

  • 9.1. Market Snapshot
  • 9.2. Global Bioengineered protein drugs Market by Drug Delivery Method, Performance - Potential Analysis
  • 9.3. Global Bioengineered protein drugs Market Estimates & Forecasts by Drug Delivery Method 2019-2029 (USD Billion)
  • 9.4. Bioengineered protein drugs Market, Sub Segment Analysis
    • 9.4.1. Traditional Methods
    • 9.4.2. Novel approaches according to recent research

Chapter 10. Global Bioengineered protein drugs Market, Regional Analysis

  • 10.1. Bioengineered protein drugs Market, Regional Market Snapshot
  • 10.2. North America Bioengineered protein drugs Market
    • 10.2.1. U.S. Bioengineered protein drugs Market
      • 10.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
      • 10.2.1.2. Diseases breakdown estimates & forecasts, 2019-2029
      • 10.2.1.3. Technology breakdown estimates & forecasts, 2019-2029
      • 10.2.1.4. Drug Delivery Method breakdown estimates & forecasts, 2019-2029
    • 10.2.2. Canada Bioengineered protein drugs Market
  • 10.3. Europe Bioengineered protein drugs Market Snapshot
    • 10.3.1. U.K. Bioengineered protein drugs Market
    • 10.3.2. Germany Bioengineered protein drugs Market
    • 10.3.3. France Bioengineered protein drugs Market
    • 10.3.4. Spain Bioengineered protein drugs Market
    • 10.3.5. Italy Bioengineered protein drugs Market
    • 10.3.6. Rest of Europe Bioengineered protein drugs Market
  • 10.4. Asia-Pacific Bioengineered protein drugs Market Snapshot
    • 10.4.1. China Bioengineered protein drugs Market
    • 10.4.2. India Bioengineered protein drugs Market
    • 10.4.3. Japan Bioengineered protein drugs Market
    • 10.4.4. Australia Bioengineered protein drugs Market
    • 10.4.5. South Korea Bioengineered protein drugs Market
    • 10.4.6. Rest of Asia Pacific Bioengineered protein drugs Market
  • 10.5. Latin America Bioengineered protein drugs Market Snapshot
    • 10.5.1. Brazil Bioengineered protein drugs Market
    • 10.5.2. Mexico Bioengineered protein drugs Market
    • 10.5.3. Rest of Latin America Bioengineered protein drugs Market
  • 10.6. Rest of The World Bioengineered protein drugs Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. Amgen
    • 11.2.3. Baxter Healthcare
    • 11.2.4. Bayer Healthcare Pharmaceuticals
    • 11.2.5. Eli Lilly And Co.
    • 11.2.6. GlaxoSmithKline
    • 11.2.7. Hoffman-la-Roche
    • 11.2.8. Johnson And Johnson
    • 11.2.9. Merck And Co. Inc.,
    • 11.2.10. Fresenius Kabi USA

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Bioengineered protein drugs Market, report scope
  • TABLE 2. Global Bioengineered protein drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Bioengineered protein drugs Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
  • TABLE 4. Global Bioengineered protein drugs Market estimates & forecasts by Diseases 2019-2029 (USD Billion)
  • TABLE 5. Global Bioengineered protein drugs Market estimates & forecasts by Technology 2019-2029 (USD Billion)
  • TABLE 6. Global Bioengineered protein drugs Market estimates & forecasts by Drug Delivery Method 2019-2029 (USD Billion)
  • TABLE 7. Global Bioengineered protein drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Bioengineered protein drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Bioengineered protein drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Bioengineered protein drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Bioengineered protein drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Bioengineered protein drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Bioengineered protein drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Bioengineered protein drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Bioengineered protein drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. Global Bioengineered protein drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 18. U.S. Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. U.S. Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 21. Canada Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. Canada Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 24. UK Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. UK Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 27. Germany Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. Germany Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 30. France Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. France Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 33. Italy Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Italy Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 36. Spain Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. Spain Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 39. RoE Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. RoE Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 42. China Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. China Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 45. India Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. India Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 48. Japan Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. Japan Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 51. South Korea Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. South Korea Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 54. Australia Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. Australia Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. RoAPAC Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 60. Brazil Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Brazil Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 63. Mexico Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. Mexico Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 66. RoLA Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. RoLA Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 69. Row Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. Row Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 71. List of secondary sources, used in the study of global Bioengineered protein drugs Market
  • TABLE 72. List of primary sources, used in the study of global Bioengineered protein drugs Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Bioengineered protein drugs Market, research methodology
  • FIG 2. Global Bioengineered protein drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Bioengineered protein drugs Market, key trends 2021
  • FIG 5. Global Bioengineered protein drugs Market, growth prospects 2022-2029
  • FIG 6. Global Bioengineered protein drugs Market, porters 5 force model
  • FIG 7. Global Bioengineered protein drugs Market, pest analysis
  • FIG 8. Global Bioengineered protein drugs Market, value chain analysis
  • FIG 9. Global Bioengineered protein drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Bioengineered protein drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Bioengineered protein drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Bioengineered protein drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Bioengineered protein drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Bioengineered protein drugs Market, regional snapshot 2019 & 2029
  • FIG 15. North America Bioengineered protein drugs Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Bioengineered protein drugs Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Bioengineered protein drugs Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Bioengineered protein drugs Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Bioengineered protein drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable